Roche proposes former Takeda CEO for board seat

Swiss healthcare group Roche has proposed Christoph Weber, the former chief executive of Takeda Pharmaceuticals, for election to its board. According to Business Recorder, the company made the proposal on Wednesday, ahead of its annual general meeting next March.

Chairman Severin Schwan said in a statement, quoted in the report, that Weber's deep familiarity with the healthcare sector and his wide leadership background would add strength to the board. Shareholders will decide on the nomination at that meeting, which is scheduled for March.

The report, datelined Zurich, contains no financial figures. It also gives no details on Weber's proposed role or on any other board changes. For readers, the item is a governance announcement that does not report any change in Roche's financial position.